|
|
News Breaks | | | | September 10, 2012 | | 07:11 EDT |  | CTIX | Cellceutix plans for European funded Leukemia Phase 1 trial
Cellceutix announced that it is in discussions with a major university in Europe wishing to conduct clinical trials on Kevetrin, the company's flagship anti-cancer compound. The University, which is ranked in the top ten of universities in Europe by review firm 4 International Colleges & Universities wishes to test Kevetrin as a combination therapy for leukemia with drugs proprietary to one of the world's largest pharmaceutical companies. Pursuant to a confidentiality agreement, Cellceutix cannot identify the University or the pharmaceutical company at this time. | |
|
News For CTIX From The Last 14 Days Check below for free stories on CTIX the last two weeks. |
|
|
| May 15, 2013 | | 07:36 EDT |  | CTIX | Three Part Advisors to host a conference
 Subscribe for More Information | |
|
|
|
|
|
|
